SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001393905-20-000208
Filing Date
2020-07-06
Accepted
2020-07-06 15:47:32
Documents
2
Period of Report
2020-06-30
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rtsl_8k.htm 8-K 21488
2 SECURITIES PURCHASE AGREEMENT BETWEEN RAPID THERAPEUTIC SCIENCE LABORATORIES, IN rtsl_ex101.htm EX-10.1 58488
  Complete submission text file 0001393905-20-000208.txt   81391
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55018 | Film No.: 201013429
SIC: 2834 Pharmaceutical Preparations